Company profile AMLX
After 39 days of this quarter the interest is at 114.0. Based on that we can calculate that during remaining 52 days it will total up to 266.0. Amylyx Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+111.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 31 | 61 96.8% QoQ | 35 -42.6% QoQ | 81 131.4% QoQ |
| 2020 | 81 161.3% YoY 0.0% QoQ | 104 70.5% YoY 28.4% QoQ | 78 122.9% YoY -25.0% QoQ | 71 -12.3% YoY -9.0% QoQ |
| 2021 | 32 -60.5% YoY -54.9% QoQ | 15 -85.6% YoY -53.1% QoQ | 127 62.8% YoY 746.7% QoQ | 157 121.1% YoY 23.6% QoQ |
| 2022 | 331 934.4% YoY 110.8% QoQ | 127 746.7% YoY -61.6% QoQ | 204 60.6% YoY 60.6% QoQ | 148 -5.7% YoY -27.5% QoQ |
| 2023 | 126 -61.9% YoY -14.9% QoQ | 132 3.9% YoY 4.8% QoQ | 299 46.6% YoY 126.5% QoQ | 239 61.5% YoY -20.1% QoQ |
| 2024 | 114 -9.5% YoY -52.3% QoQ | - | - | - |
The average 5 years interest of Amylyx Pharmaceuticals was 9.93 per week. The last year interest of Amylyx Pharmaceuticals compared to the last 5 years has changed by 58.61%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 202.3%.
Google Trends for RELYVRIO
Q4 -68.6% YoY, +25.4% QoQ | Q1 -62.3% YoY, -41.9% QoQ | Correlation: 0.34
After 39 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 52 days it will total up to 56.0. RELYVRIO expected interest is significantly lower compared to same quarter last year (-46.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 6 | 4 -33.3% QoQ | 5 25.0% QoQ | 7 40.0% QoQ |
| 2020 | 2 -66.7% YoY -71.4% QoQ | 2 -50.0% YoY 0.0% QoQ | 6 20.0% YoY 200.0% QoQ | 9 28.6% YoY 50.0% QoQ |
| 2021 | 4 100.0% YoY -55.6% QoQ | 6 200.0% YoY 50.0% QoQ | 4 -33.3% YoY -33.3% QoQ | 3 -66.7% YoY -25.0% QoQ |
| 2022 | 4 0.0% YoY 33.3% QoQ | 3 -50.0% YoY -25.0% QoQ | 30 650.0% YoY 900.0% QoQ | 225 7400.0% YoY 650.0% QoQ |
| 2023 | 105 2525.0% YoY -53.3% QoQ | 62 1966.7% YoY -41.0% QoQ | 55 83.3% YoY -11.3% QoQ | 74 -67.1% YoY 34.5% QoQ |
| 2024 | 24 -77.1% YoY -67.6% QoQ | - | - | - |
The average 5 years interest of RELYVRIO was 2.45 per week. The last year interest of RELYVRIO compared to the last 5 years has changed by 109.39%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1121.43%.
There is not enough data for Amylyx Pharmaceuticals ALS to provide analysis
There is not enough data for Amylyx Pharmaceuticals ALS to provide correlation calculation
There is not enough data for Amylyx Pharmaceuticals ALS to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. ALBRIOZA expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 75 | 165 120.0% QoQ | 88 -46.7% QoQ | 115 30.7% QoQ |
| 2020 | 16 -78.7% YoY -86.1% QoQ | 0 -100.0% YoY -100.0% QoQ | 61 -30.7% YoY inf% QoQ | 173 50.4% YoY 183.6% QoQ |
| 2021 | 40 150.0% YoY -76.9% QoQ | 0 150.0% YoY -100.0% QoQ | 17 -72.1% YoY inf% QoQ | 104 -39.9% YoY 511.8% QoQ |
| 2022 | 14 -65.0% YoY -86.5% QoQ | 223 inf% YoY 1492.9% QoQ | 211 1141.2% YoY -5.4% QoQ | 81 -22.1% YoY -61.6% QoQ |
| 2023 | 38 171.4% YoY -53.1% QoQ | 46 -79.4% YoY 21.1% QoQ | 83 -60.7% YoY 80.4% QoQ | 54 -33.3% YoY -34.9% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of ALBRIOZA was 6.15 per week. The last year interest of ALBRIOZA compared to the last 5 years has changed by -30.89%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -50.12%.
There is not enough data for Neurodegenerative disease treatments to provide analysis
There is not enough data for Neurodegenerative disease treatments to provide correlation calculation
There is not enough data for Neurodegenerative disease treatments to provide analysis
There is not enough data for Amylyx Pharmaceuticals jobs to provide analysis
There is not enough data for Amylyx Pharmaceuticals jobs to provide correlation calculation
There is not enough data for Amylyx Pharmaceuticals jobs to provide analysis
There is not enough data for Amylyx Pharmaceuticals reviews to provide analysis
There is not enough data for Amylyx Pharmaceuticals reviews to provide correlation calculation
There is not enough data for Amylyx Pharmaceuticals reviews to provide analysis
After 39 days of this quarter the interest is at 273.0. Based on that we can calculate that during remaining 52 days it will total up to 637.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 419 | 598 42.7% QoQ | 538 -10.0% QoQ | 603 12.1% QoQ |
| 2020 | 688 64.2% YoY 14.1% QoQ | 633 5.9% YoY -8.0% QoQ | 510 -5.2% YoY -19.4% QoQ | 475 -21.2% YoY -6.9% QoQ |
| 2021 | 665 -3.3% YoY 40.0% QoQ | 494 -22.0% YoY -25.7% QoQ | 418 -18.0% YoY -15.4% QoQ | 532 12.0% YoY 27.3% QoQ |
| 2022 | 521 -21.7% YoY -2.1% QoQ | 546 10.5% YoY 4.8% QoQ | 685 63.9% YoY 25.5% QoQ | 565 6.2% YoY -17.5% QoQ |
| 2023 | 676 29.8% YoY 19.6% QoQ | 486 -11.0% YoY -28.1% QoQ | 586 -14.5% YoY 20.6% QoQ | 532 -5.8% YoY -9.2% QoQ |
| 2024 | 273 -59.6% YoY -48.7% QoQ | - | - | - |
The average 5 years interest of Biotechnology companies was 43.84 per week. The last year interest of Biotechnology companies compared to the last 5 years has changed by -0.55%. The interest for Biotechnology companies is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -5.65%.
There is not enough data for Cambridge, MA biotech to provide analysis
There is not enough data for Cambridge, MA biotech to provide correlation calculation
There is not enough data for Cambridge, MA biotech to provide analysis
After 39 days of this quarter the interest is at 73.0. Based on that we can calculate that during remaining 52 days it will total up to 170.0. Amylyx Pharmaceuticals -stock -company expected interest is significantly lower compared to previous quarter (-54.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 81 | 30 -63.0% QoQ | 0 -100.0% QoQ | 230 inf% QoQ |
| 2020 | 161 98.8% YoY -30.0% QoQ | 133 343.3% YoY -17.4% QoQ | 57 inf% YoY -57.1% QoQ | 55 -76.1% YoY -3.5% QoQ |
| 2021 | 49 -69.6% YoY -10.9% QoQ | 124 -6.8% YoY 153.1% QoQ | 319 459.6% YoY 157.3% QoQ | 239 334.5% YoY -25.1% QoQ |
| 2022 | 314 540.8% YoY 31.4% QoQ | 215 73.4% YoY -31.5% QoQ | 260 -18.5% YoY 20.9% QoQ | 280 17.2% YoY 7.7% QoQ |
| 2023 | 186 -40.8% YoY -33.6% QoQ | 344 60.0% YoY 84.9% QoQ | 239 -8.1% YoY -30.5% QoQ | 371 32.5% YoY 55.2% QoQ |
| 2024 | 73 -60.8% YoY -80.3% QoQ | - | - | - |
The average 5 years interest of Amylyx Pharmaceuticals -stock -company was 14.41 per week. The last year interest of Amylyx Pharmaceuticals -stock -company compared to the last 5 years has changed by 49.06%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 152.71%.